The Patient Advisory Committee (PAC) has been instrumental to Hypo-Resolve from the beginning of the project. The role of the PAC is to give voice to their insights, desire and experiences to help ensure that Hypo-RESOLVE’s direction, goals and strategy are closely aligned with the goals of people living with, and affected by diabetes.
The Patient Advisory Committee is working within and across Work Packages serving as an advisory resource to Hypo-RESOLVE by for example:
Advising the different work packages around PwD aspects
Providing advice for the design of clinical trials and informed consent wording
Advising on communication of results to the wider public
Helping disseminate information through PwD community networks
Our committee, consisting of seven people with type 1 or type 2 diabetes, representatives from the patient organizations IDF and JDRF and representatives from NovoNordisk, helps to ensure that Hypo-RESOLVE operates with a patient-centric approach and delivers specific outcomes with the potential to improve the lives of people with diabetes.